Syquant Capital SAS
ABVX icon

Syquant Capital SAS’s Abivax ABVX Stock Holding History

Syquant Capital SAS’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.88M Buy
77,500
+38,000
+96% +$4.58M 1.52% 6
2026
Q2 		$5.26M Sell
39,500
-3,000
-7% -$340K 1.18% 8
2026
Q1 		$4.73M Buy
+42,500
New +$5.03M 0.74% 14

Other funds holding ABVX

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return
Vilga Financial Planning
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
Colonial River Investments
Colonial River Investments Midlothian, Virginia $387M AUM 30.41% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Sax Wealth Advisors
Sax Wealth Advisors Parsippany, New Jersey $3.5B AUM 13.73% 1-Year Est. Return
Guardian Partners
Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return
Burns Matteson Capital Management
Burns Matteson Capital Management Corning, New York $289M AUM 39.67% 1-Year Est. Return

Syquant Capital SAS's ABVX Position: Q3 2026 in Review

Syquant Capital SAS increased its Abivax (ABVX) stake by 96% in Q3 2026, buying an estimated $4.58M and bringing the position to 77,500 shares worth $6.88M. The position accounts for 1.52% of the portfolio, ranked #6.

Syquant Capital SAS first reported a position in ABVX in Q1 2026 and has held it in 3 quarters since. 36 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Syquant Capital SAS held 77,500 shares of Abivax worth $6.88M as of Q3 2026.
  • Syquant Capital SAS bought 38,000 Abivax shares in Q3 2026, an estimated $4.58M.
  • Abivax made up 1.52% of Syquant Capital SAS's portfolio in Q3 2026, its #6 holding.
  • Syquant Capital SAS first reported a position in Abivax in Q1 2026 and has held it in 3 quarters since.
  • 36 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Syquant Capital SAS's 13F filing for Q3 2026, filed 20 Oct 2026.